Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indivior Pharmaceuticals Inc. Common Stock (INDV) vs Snowflake Inc (SNOW) Price & Performance

Indivior Pharmaceuticals Inc. Common StockTrade
Snowflake IncTrade

Price performance (Past 24H)

Key statistics

Indivior Pharmaceuticals Inc. Common Stock vs Snowflake Inc — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.3 (market cap $4.18B), while Snowflake Inc trades at $327.82 (market cap $126.22B). The key difference: Snowflake Inc is far larger — about 30.2× Indivior Pharmaceuticals Inc. Common Stock's market cap, and Snowflake Inc is trading nearer its 52-week high, Indivior Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and Snowflake Inc for 53 Days on average.

INDVSNOW
Market Cap
$4.18B$126.22B
Volume
1,819,7464,112,138
Sector
HealthTechnology
52-Week High
$41.83$368.89
52-Week Low
$24.09$121.11
Typical Hold Time
0 Days53 Days
Enterprise Value
$4.47B$126.64B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Indivior Pharmaceuticals Inc. Common Stock

No Aura AI signal available yet.

Snowflake Inc

Snowflake (SNOW) trades at $357.76, down 0.72% today, with strong technical momentum showing bullish moving averages and support at $355. The company demonstrates robust revenue growth, reaching $3.63 billion in 2025, though it remains unprofitable with a -20.07% net margin. Recent earnings have consistently beaten expectations, and analyst sentiment is overwhelmingly positive with 81% buy ratings and a $418.03 consensus target.

The outlook remains constructive given strong revenue growth and strategic partnerships, but investors face risks from continued losses, high valuation multiples (P/S 22.66), and potential dilution from the recent $3.75 billion convertible note offering. The stock offers growth exposure but requires tolerance for current profitability challenges.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INDV
100% Buy0% Sell
Avg holding period · 0 Days
SNOW
95% Buy5% Sell
Avg holding period · 53 Days

Top news

Latest headlines on both assets

About Indivior Pharmaceuticals Inc. Common Stock

Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.

Read more on INDV →

About Snowflake Inc

Founded in 2012, Snowflake is a data lake, warehousing, and sharing company that came public in 2020. To date, the company has over 3,000 customers including nearly 30% of the Fortune 500 as its customers. Snowflake's data lake stores unstructured and semistructured data that can then be used in analytics to create insights stored in its data warehouse. Snowflake's data sharing capability allows enterprises to easily buy and ingest data almost instantaneously compared with a traditionally months-long process. Overall, the company is known for the fact that all of its data solutions that can be hosted on various public clouds.

Read more on SNOW →